Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

CATX

Perspective Therapeutics (CATX)

Perspective Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:CATX
DatumZeitQuelleÜberschriftSymbolFirma
24/01/202513h26Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
24/01/202513h00GlobeNewswire Inc.Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers SymposiumAMEX:CATXPerspective Therapeutics Inc
22/01/202513h00GlobeNewswire Inc.Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET to be Presented at the ASCO Gastrointestinal Cancers Symposium on January 24, 2025AMEX:CATXPerspective Therapeutics Inc
13/01/202514h36Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
13/01/202514h00GlobeNewswire Inc.Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare ConferenceAMEX:CATXPerspective Therapeutics Inc
10/01/202513h00GlobeNewswire Inc.Perspective Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceAMEX:CATXPerspective Therapeutics Inc
07/01/202522h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
07/01/202522h48Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
06/01/202514h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
06/01/202514h00GlobeNewswire Inc.Perspective Therapeutics Appoints Juan Graham, MBA as Chief Financial OfficerAMEX:CATXPerspective Therapeutics Inc
06/12/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
04/12/202423h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
04/12/202423h17Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]AMEX:CATXPerspective Therapeutics Inc
04/12/202423h15Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]AMEX:CATXPerspective Therapeutics Inc
27/11/202413h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
27/11/202413h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
27/11/202413h00GlobeNewswire Inc.Perspective Therapeutics to Participate in Upcoming Investor Conferences in DecemberAMEX:CATXPerspective Therapeutics Inc
26/11/202413h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
21/11/202413h30Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
21/11/202413h15GlobeNewswire Inc.Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical SymposiumAMEX:CATXPerspective Therapeutics Inc
15/11/202422h08GlobeNewswire Inc.Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024AMEX:CATXPerspective Therapeutics Inc
15/11/202413h30Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
15/11/202400h14Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:CATXPerspective Therapeutics Inc
14/11/202422h05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:CATXPerspective Therapeutics Inc
14/11/202416h24Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:CATXPerspective Therapeutics Inc
12/11/202422h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CATXPerspective Therapeutics Inc
12/11/202422h07Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
12/11/202422h05GlobeNewswire Inc.Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 ResultsAMEX:CATXPerspective Therapeutics Inc
31/10/202412h00GlobeNewswire Inc.Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial ResultsAMEX:CATXPerspective Therapeutics Inc
29/10/202412h00GlobeNewswire Inc.Perspective Therapeutics to Participate in Upcoming Investor Conferences in NovemberAMEX:CATXPerspective Therapeutics Inc
 Showing the most relevant articles for your search:AMEX:CATX